Karin Franck‐Larsson

Type I interferon system activation and association with disease manifestations in systemic sclerosis

Maija‐Leena Eloranta, Karin Franck‐Larsson, Tanja Lövgren et al. · Annals of the Rheumatic Diseases · 2010 · 196 citations

Life Sciences, Clinical Sciences, Immunology +17

Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis

Ronald van Vollenhoven, Mikkel Østergaard, Marjatta Leirisalo‐Repo et al. · Annals of the Rheumatic Diseases · 2015 · 134 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Lack of evidence of stimulatory autoantibodies to platelet‐derived growth factor receptor in patients with systemic sclerosis

Jean-François Classen, Dan Henrohn, Fredrik Rorsman et al. · Arthritis & Rheumatism · 2009 · 94 citations

Life Sciences, Immunology, Pathology +17

Lower gastrointestinal symptoms and quality of life in patients with systemic sclerosis: a population-based study

Karin Franck‐Larsson, Wilhelm Graf, Anders Rönnblom · European Journal of Gastroenterology & Hepatology · 2009 · 68 citations

Medicine, Clinical Sciences, Bowel Management +14

Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity

Karin Franck‐Larsson, Hans Hedenström, Rasmus Holmboe Dahl et al. · Scandinavian Journal of Rheumatology · 2003 · 52 citations

Medicine, Clinical Sciences, Physiology +16